Sinogen Biopharma logo — Pioneering the path for Chinese biotech to reach the U.S. ph...

Sinogen Biopharma

Pioneering the path for Chinese biotech to reach the U.S. pharmaceutical landscape, fostering the development and licensing of groundbreaking drugs.

Founded 2016 Series B Total: $13.00M Biopharma, Biotechnology +2

General Information

Company Name Sinogen Biopharma
Founded Year 2016
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Sinogen Biopharma. To contact Sinogen Biopharma, visit huajinpharmtech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sinogen Biopharma compare?

A PDF of Sinogen Biopharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sinogen Biopharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sinogen Biopharma

Sinogen Biopharma is pioneering the path for Chinese biotech to reach the U.S. pharmaceutical landscape with a vision to bridge China's biotech innovation to the US pharma market. Founded in 2016, the company is dedicated to fostering the development and licensing of groundbreaking drugs from China. Specializing in Biopharma, Biotechnology, Health Care, and Pharmaceutical industries, Sinogen Biopharma received a Series B investment on 31 December 2023 from Hebei Coastal Industry Investment Fund Management, Ningbo Zhuoxuan, and Puxin Capital. This investment signifies a crucial milestone as the company continues its mission to introduce innovative drugs to the global market.

Business keywords: Biotech, Pharmaceuticals, Drug Development, Innovation, Licensing, China, US Market, Biopharma, Research, Science, Global Expansion

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Undisclosed 3
Hebei Coastal Industry Investment Fund Management, Ningbo Zhuoxuan +1
31 Dec 2023
Series B $10.00M 3
Westlake Village BioPartners, Winzac Capital +1
23 May 2022
Venture Round $3.00M 1
Qiming Venture Partners
01 Dec 2021

Sinogen Biopharma Alternatives & Competitors

View All Alternatives
Sinogen Biopharma vs
Abzena
Abzena United States

Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly movin...

Private Equity
436 employees
Biopharma, Biotechnology
Sinogen Biopharma vs

With state-of-the-art facilities and a pioneering team, we bring advanced generic drugs to the U.S....

Venture round
51-200 employees
Health Care, Manufacturing
Sinogen Biopharma vs

Micar Innovation - Drug Discovery Factory for novel drug molecules (structure based in silico drug d...

3 employees
AI, Biotechnology

FAQ About Sinogen Biopharma

Pioneering the path for Chinese biotech to reach the U.S. pharmaceutical landscape, fostering the development and licensing of groundbreaking drugs.
Sinogen Biopharma was founded in 2016.
Sinogen Biopharma operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Biotech, Pharmaceuticals, Drug Development and Innovation.
Sinogen Biopharma has completed 3 funding rounds, raising a total of $13.00M. The latest funding stage is Series B.
Top alternatives and competitors to Sinogen Biopharma include Abzena, Novast, Micar Innovation (Micar21), Archimedes Pharma, HUYABIO International. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sinogen Biopharma and Abzena are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sinogen Biopharma, https://bouncewatch.com/company/sinogen-biopharma, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes